Previous 10 | Next 10 |
2023-07-28 05:31:08 ET Summary Arcutis has launched Zoryve, a topical cream for the treatment of psoriasis, and is focused on transitioning to a commercial-stage company. The company has made progress with major pharmacy benefit managers and positioned Zoryve to be highly accessib...
WESTLAKE VILLAGE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will host a conference call and webcast...
Coverage at CVS Caremark, the largest pharmacy benefit manager (PBM) in the United States was effective July 5 All three of the largest pharmacy benefit managers in the United States have now included ZORYVE on formulary, providing access to 80% of commercial lives ZORYVE is a once-daily,...
2023-07-12 17:31:16 ET Gainers: Evolus ( NASDAQ: EOLS ) +5% . Omega Therapeutics ( OMGA ) +5% . Kodiak Sciences ( KOD ) +4% . Amazon ( AMZN ) +4% . Cara Therapeutics ( CARA ) +3% . Losers: ViaSat ( VSAT ) -7% ...
2023-07-12 12:49:58 ET Summary Arcutis Biotherapeutics' FDA-approved product, Zoryve, targets plaque psoriasis and is being developed for other dermatological diseases. The company's Q1 2023 revenues were $2.8 million, with a net loss of $80.1 million. The company faces intense co...
2023-06-28 17:34:03 ET Gainers: American Outdoor Brands ( AOUT ) +9% . Overstock ( OSTK ) +5% . Purple Innovation ( PRPL ) +5% . Farmer Brothers ( FARM ) +5% . Arcutis Biotherapeutics ( ARQT ) +4% . Losers: CorMedix...
2023-06-15 17:38:38 ET Gainers: Adobe ( ADBE ) +5% . Arcturus Therapeutics ( ARCT ) +5% . Xeris Biopharma Holdings ( XERS ) +4% . Castle Biosciences ( CSTL ) +4% . Enovix Corporation ( ENVX ) +4% . Losers: Mil...
2023-06-09 17:33:00 ET Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence . The medical dermatology company's stock closed last week at $8.20 and rose to as h...
Senior Vice President and Chief Commercial Officer (CCO) Ken Lock Stepping Down Ayisha Jeter Appointed Interim CCO WESTLAKE VILLAGE, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focus...
2023-05-13 19:53:08 ET Arcutis Biotherapeutics, Inc. (ARQT) Q1 2023 Results Conference Call May 09, 2023 04:30 PM ET Company Participants Eric McIntyre - Head of Investor Relations Frank Watanabe - President & Chief Executive Officer Patrick Burnett - Chief M...
News, Short Squeeze, Breakout and More Instantly...
Arcutis Biotherapeutics Inc. Company Name:
ARQT Stock Symbol:
NASDAQ Market:
Arcutis Biotherapeutics Inc. Website:
ZORYVE cream provides rapid relief, with efficacy, safety, and tolerability demonstrated up to 56 weeks of treatment ZORYVE cream rapidly and significantly reduces itch, the most bothersome symptom of atopic dermatitis (AD) Once-daily cream is for use anywhere on the body for any duration...
WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that the Company has been in communication with the U....
2024-06-16 18:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...